Diabetes, Cardiovascular Risks, and Lipoproteins
This cluster of papers focuses on the metabolic syndrome, its association with cardiovascular disease, diabetes, insulin resistance, obesity, and atherosclerosis. It includes studies on glucose metabolism, lifestyle interventions, and global prevalence of related conditions.
Papers listed on taxonomy pages are the top few works per node from the OpenAlex snapshot. That list is not exhaustive and is not an endorsement. The topic map and the journal registry remain separate: there is still no authoritative topic-to-venue or topic-to-organization edge. Search is a lexical lookup, not a claim that a venue publishes a topic.
Most cited
- Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
- Global Prevalence of Diabetes
- Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation
- Harmonizing the Metabolic Syndrome
Most recent
- The role of dimethylguanidino valeric acid (DMGV)-related metabolic pathways in carbohydrate and lipid metabolism
- The Hidden Metabolic Vulnerability in HDL Cholesterol in an Afro-Caribbean Type 2 Diabetes Population Less Vulnerable to Heart Disease
- Storage symptom burden in women with obesity is associated more with age and smoking than metabolic biomarkers: prospectively collected cross-sectional data
- Comparing the diagnostic value of different obesity indices in prediabetes: a cross-sectional study in China
- Cross-sectional evaluation of anthropometric measures vs MRI-measured visceral and hepatic fat in a Canadian cohort
- MAGNITUDE OF METABOLIC SYNDROME AND ITS ASSOCIATED FACTORS AMONG TYPE 2 DIABETIC ADULT PATIENTS ON FOLLOW-UP AT WOLLEGA UNIVERSITY COMPREHENSIVE SPECIALIZED HOSPITAL, EAST WOLLEGA, NEKEMTE, ETHIOPIA, 2026